Vogue Beautyさんのインスタグラム写真 - (Vogue BeautyInstagram)「On Tuesday, the FDA approved the first drug designed specifically to treat postpartum depression, marking a vital new chapter for women and physicians alike. Up to one in seven women suffer from the most extreme form of postnatal adjustment—postpartum depression—which is a severe form of clinical depression brought on by pregnancy and childbirth that can last for months or even years. The new treatement, Zulresso, is administered in a single 60-hour session, clinical trials have shown it to successfully treat symptoms of postpartum depression within 48 hours. In fact, in a company-funded study of new mothers, half of the women given Zulresso had their moderate or severe postpartum depression end within two and a half days. Tap the link in our bio to read more about this game-changing drug, including its potential shortcomings and what it means for the future of women’s health. Photographed by #IrvingPenn, Vogue, September 1996」3月22日 7時06分